incompatibility of iv drugs dr. s.s. badri pharm.d, bcps department of clinical pharmacy isfahan...

38
Incompatibility of IV Drugs Dr. S.S. Badri Dr. S.S. Badri Pharm.D , BCPS Pharm.D , BCPS Department of Clinical Pharmacy Department of Clinical Pharmacy Isfahan University of Medical Isfahan University of Medical Sciences Sciences

Upload: austin-baldwin

Post on 04-Jan-2016

213 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences

Incompatibility of

IV Drugs

Dr. S.S. Badri Dr. S.S. Badri Pharm.D , BCPSPharm.D , BCPS

Department of Clinical Department of Clinical PharmacyPharmacyIsfahan University of Medical Isfahan University of Medical SciencesSciences

Page 2: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences

Definit

ion

Definit

ion

Drug Incompatibility

Drug Incompatibility refers to interactions

refers to interactions

between two or more

between two or more

substances which lead

substances which lead

to changes in

to changes in chemicalchemical, , physical

physical, , therapeutictherapeutic properties

properties

of the pharmaceutical

of the pharmaceutical

dosage form.

dosage form.

Incompatibility of IV Drugs

2

Page 3: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences

Types of Drug Incompatibility

1. Therapeutic incompatibilitymodification of the therapeutic effect of one drug by the prior concomitant administration of another (Drug interactions).

2. Physical incompatibilityInteraction between two or more substances which lead to change

in color, odor, taste, viscosity and morphology (pharmaceutical incompatibilities).

3. Chemical incompatibilityReaction between two or more substances which lead to change in

chemical properties of pharmaceutical dosage form.

Page 4: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences

Physical Incompatibility

• Insolubility– Change in pH– Any change that may lead to precipitation of drugs and

change in their properties.

Chemical Incompatibility

• Oxidation– Light → photo-chemical reactions– pH : each drug has its ideal pH for stability. Any change

in pH affect drug stability and may accelerate oxidation reaction.

Page 5: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences

• Physical incompatibilities result in visible (precipitate, color change, gas production) and invisible (sub-visible particles, variations in pH) reactions, and even in the absence of precipitate could result in a significant reduction in the amount of drug delivered to the patient.

• Chemical incompatibilities can lead to a decrease in drug delivery, drug degradation, and/or formation of toxic products.

Page 6: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences

Mix

ing

inco

mpa

tibl

e m

edic

atio

ns

• Mixing incompatible medications is a major IV medication error.

• Although critically ill patients usually have multiple central IV lines, several medications have to be infused simultaneously through the same lines.

• Investigations have shown that mixing an IV drug with the wrong diluents can occur in up to 80% of the cases.

• This is alarming especially in the ICU where 25% of the IV incompatibilities are highly significant and 26% are life-threatening.

Page 7: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences

انواع و ویژگی های فیزیکوشیمیایی محلول های تزریقی

IV Solution Glucose(g/L)

Na(mEq/L)

Cl(mEq/L)

K(mEq/L)

CaOsmolality(mOsm/L)

Normal Saline (NS) 0 154 154 0 0 308

Ringer’s Lactate (RL) 0 130 109 4 3 272

Dextrose Water, 5% (DW 5%) 50 0 0 0 0 278

DW5% in Saline (0.9%) 50 154 154 0 0 560

Half Saline (HS) 0 77 77 0 0 154

DW 3.33% + Saline 0.3% 33 51 51 0 0 270

Page 8: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences

• Reaction of IV medications when mixed together resulting in solutions that are no longer optimal for the patient.

• The stability is altered by physico-chemical reactions leading to decreased effectiveness of the drug or an increased micro-particles load leading ultimately to therapeutic failure, catheter occlusion or embolism.

Page 9: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 10: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 11: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 12: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences

When the dilution or mixing of the salt or ionized forms of organic drugs results in precipitation, the most likely cause is formation of the non-ionized drug forms.

when ceftriaxone sodium is diluted in lactated Ringer's injection, precipitation can occur despite the alkaline pH of lactated Ringer's maintaining the ionized

water-soluble form of ceftriaxone.

The problem in this case is the formation of a poorly soluble calcium salt of

ceftriaxone, the ionized form of which is a divalent anion.

Page 13: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 14: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 15: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 16: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 17: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 18: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 19: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 20: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences

IV drug compatibilities based on the pH

The pH of solution was one of the compatibility measure used in the establishment of standard concentrations of medications commonly given by continuous infusion and prepared at the bedside.

Vilma Loubnan, Soumana C Nasser.[Lebanese American University, Beirut, Lebanon]A Guide on Intravenous Drug Compatibilities Based on Their pH.International Journal of Comprehensive Pharmacy (IJCP) 2010; 1(5): 1-9.

Page 21: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences

Medications admixture into a solution could alter the pH to acidic or basic depending on the solution buffer capacity. •Normal Saline (NS) and Dextrose 5% in water (D5W) solutions have low buffer capacity, so that the solution will turn acidic with the admixture of an acidic medication, and it will turn basic with the admixture of a basic medication. •Lactated Ringer’s (LR) solution has a high buffer capacity, so that when adding an acidic medication, the solution will either remain neutral or the pH will drop to a lesser extent than that observed with NS or D5W solution.

Page 22: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 23: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 24: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 25: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 26: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 27: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 28: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 29: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 30: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 31: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 32: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 33: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences

Furosemide-Midazolam incompatibility

• Even in the absence of visible particles, precipitation of furosemide led to a drug loss estimated at between 10 % and 15 %.

• Furosemide is more impacted by interaction because the pH of the mixture is acid and this form is poorly soluble in an aqueous solution.

• Physical incompatibility between furosemide and midazolam leads to a significant reduction in drug delivered to the patient and may result in treatment failure.

Page 34: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 35: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 36: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 37: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences
Page 38: Incompatibility of IV Drugs Dr. S.S. Badri Pharm.D, BCPS Department of Clinical Pharmacy Isfahan University of Medical Sciences